These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene. Panchenko AV; Fedoros EI; Pigarev SE; Maydin MA; Gubareva EA; Kireeva GS; Tyndyk ML; Kuznetsova AI; Nekhaeva TL; Danilova AB; Baldueva IA; Anisimov VN Integr Cancer Ther; 2019; 18():1534735419833778. PubMed ID: 30841763 [TBL] [Abstract][Full Text] [Related]
7. [Effect of 5-mercapto-6-azauracil and cysteine on the toxicity of cyclophosphamide]. Timar M; Vrejoiu G; Teodorescu M; Eneskcu L Farmakol Toksikol; 1968; 31(6):741-2. PubMed ID: 5756534 [No Abstract] [Full Text] [Related]
8. Antitumour and toxic effects on Wistar rats of two new platinum complexes. Charalabopoulos K; Karkabounas S; Ioachim E; Papalimneou V; Syrigos K; Evangelou A; Agnantis N; Hadjiliadis N Eur J Clin Invest; 2002 Feb; 32(2):129-33. PubMed ID: 11895460 [TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163 [TBL] [Abstract][Full Text] [Related]
10. Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF. Poikonen P; Saarto T; Lundin J; Joensuu H; Blomqvist C Br J Cancer; 1999 Aug; 80(11):1763-6. PubMed ID: 10468293 [TBL] [Abstract][Full Text] [Related]
11. Studies on the cytotoxicity of penicillamine in a rat osteogenic sarcoma. Cosolo W; Christophidis N; Drummer OH; Findlay DM Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):737-43. PubMed ID: 3467882 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). Hilgard P; Stekar J; Voegeli R; Engel J; Schumacher W; Eibl H; Unger C; Berger MR Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1457-61. PubMed ID: 3141197 [TBL] [Abstract][Full Text] [Related]
13. [The effect of sodium fluoroacetate and metformin on the antitumor activity of cyclophosphamide on the autochthonous mice sarcoma model]. Anikin IV; Goncharov NV; Tyndyk ML; Voĭshenko NG; Pliss GB; Zabezhinskiĭ MA; Popovich IG; Anisimov VN Vopr Onkol; 2014; 60(4):514-6. PubMed ID: 25552075 [TBL] [Abstract][Full Text] [Related]
14. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS]. Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071 [TBL] [Abstract][Full Text] [Related]
15. Vitamin E but not St. John's wort mitigates leukopenia caused by cancer chemotherapy in rats. Branda RF; Powden C; Brooks EM; Yildirim Z; Naud SJ; McCormack JJ Transl Res; 2006 Dec; 148(6):315-24. PubMed ID: 17162253 [TBL] [Abstract][Full Text] [Related]
16. Alkylphosphocholines: a new class of membrane-active anticancer agents. Hilgard P; Klenner T; Stekar J; Unger C Cancer Chemother Pharmacol; 1993; 32(2):90-5. PubMed ID: 8485813 [No Abstract] [Full Text] [Related]
17. [A study of the antitumor effectiveness of endoxan when administered in various ways]. Zaitseva LA; Syrkin AB Vopr Onkol; 1969; 15(11):99-101. PubMed ID: 5368849 [No Abstract] [Full Text] [Related]
18. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513 [TBL] [Abstract][Full Text] [Related]
19. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy. Focan C; Barbason H; Betz EH Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011 [TBL] [Abstract][Full Text] [Related]
20. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level. Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]